Biggest changeA reconciliation between reported net sales and net sales adjusted for the impact of divestitures and discontinued brands is as follows: (Dollars in thousands) North America International Hain Consolidated Net sales - Twelve months ended 6/30/24 $ 1,055,527 $ 680,759 $ 1,736,286 Divestitures and discontinued brands (19,519 ) (1,682 ) (21,201 ) Net sales adjusted for divestitures and discontinued brands - Twelve months ended 6/30/24 $ 1,036,008 $ 679,077 $ 1,715,085 Net sales - Twelve months ended 6/30/23 $ 1,139,162 $ 657,481 $ 1,796,643 Divestitures and discontinued brands (36,093 ) (2,662 ) (38,755 ) Net sales adjusted for divestitures and discontinued brands - Twelve months ended 6/30/23 $ 1,103,069 $ 654,819 $ 1,757,888 Net sales (decline) growth (7.3 )% 3.5 % (3.4 )% Impact of divestitures and discontinued brands 1.2 % 0.2 % 1.0 % Net sales (decline) growth adjusted for divestitures and discontinued brands (6.1 )% 3.7 % (2.4 )% Adjusted EBITDA The Company defines Adjusted EBITDA as net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses (gains), certain litigation and related costs, CEO succession costs, plant closure related costs, net, productivity and transformation costs, warehouse and manufacturing consolidation and other costs, net, costs associated with acquisitions, divestitures and other transactions, losses (gains) on sales of assets, intangibles and long-lived asset impairment and other adjustments.
Biggest changeTo adjust organic net sales for the impact of foreign exchange, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. 36 Table of Contents A reconciliation between reported net sales and organic net sales is as follows: (Dollars in thousands) North America International Hain Consolidated Net sales - Twelve months ended June 30, 2025 $ 888,626 $ 671,154 $ 1,559,780 Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories 101,789 2,771 104,560 Less: Impact of foreign currency exchange (2,074 ) 13,691 11,617 Organic net sales - Twelve months ended June 30, 2025 $ 788,911 $ 654,692 $ 1,443,603 Net sales - Twelve months ended June 30, 2024 $ 1,055,527 $ 680,759 $ 1,736,286 Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories 186,979 4,709 191,688 Organic net sales - Twelve months ended June 30, 2024 $ 868,548 $ 676,050 $ 1,544,598 Net sales decline (15.8 )% (1.4 )% (10.2 )% Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories (6.4 )% (0.2 )% (4.4 )% Less: Impact of foreign currency exchange (0.2 )% 2.0 % 0.7 % Organic net sales decline (9.2 )% (3.2 )% (6.5 )% Adjusted EBITDA The Company defines Adjusted EBITDA as net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity investees, stock-based compensation, net, unrealized and certain realized currency losses, certain litigation expenses, net, CEO succession costs, plant closure related costs, net, warehouse and manufacturing consolidation and other costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, (gains) losses on sales of assets, goodwill impairment, intangibles and long-lived asset impairment and other adjustments.
We believe that our cash flows from operations and borrowing capacity under our Credit Agreement (as defined below) will be adequate to meet anticipated operating and other expenditures for the foreseeable future. See Note 10, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
We believe that our cash flows from operations and borrowing capacity under our Credit Agreement (as defined below) will be adequate to meet anticipated operating and other expenditures for the foreseeable future. See Note 11, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.
GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S.
As of June 30, 2024, substantially all cash was held outside of the U.S. We maintain our cash and cash equivalents primarily in money market funds or their equivalent. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.
As of June 30, 2025, substantially all cash was held outside of the U.S. We maintain our cash and cash equivalents primarily in money market funds or their equivalent. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.
Management’s Discussi on and Analysis of Financial Condition and Results of Operations This Management’s Discussion and Analysis of Financial Condition and Results of Operations (this “MD&A”) should be read in conjunction with Item 1A and the Consolidated Financial Statements and the related notes thereto for the period ended June 30, 2024 included in Item 8 of this Form 10-K.
Management’s Discussi on and Analysis of Financial Condition and Results of Operations This Management’s Discussion and Analysis of Financial Condition and Results of Operations (this “MD&A”) should be read in conjunction with Item 1A and the Consolidated Financial Statements and the related notes thereto for the period ended June 30, 2025 included in Item 8 of this Form 10-K.
Forward-looking statements in this Form 10-K are qualified by the cautionary statement included under the heading, “Forward-Looking Statements” at the beginning of this Form 10-K. This MD&A generally discusses fiscal 2024 and fiscal 2023 items and year-to-year comparisons between fiscal 2024 and fiscal 2023.
Forward-looking statements in this Form 10-K are qualified by the cautionary statement included under the heading, “Forward-Looking Statements” at the beginning of this Form 10-K. This MD&A generally discusses fiscal 2025 and fiscal 2024 items and year-to-year comparisons between fiscal 2025 and fiscal 2024.
GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations and Note 20, Segment Information , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for a reconciliation of segment Adjusted EBITDA.
GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations and Note 21, Segment Information , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for a reconciliation of segment Adjusted EBITDA.
During the fiscal year ended June 30, 2024, the Company did not repurchase any shares under the repurchase program. As of June 30, 2024, the Company had $173.5 million of remaining authorization under the share repurchase program. Reconciliation of Non-U.S. GAAP Financial Measures to U.S.
During the fiscal year ended June 30, 2025, the Company did not repurchase any shares under the repurchase program. As of June 30, 2025, the Company had $173.5 million of remaining authorization under the share repurchase program. Reconciliation of Non-U.S. GAAP Financial Measures to U.S.
Intangibles and Long-Lived Asset Impairment During the fiscal year ended June 30, 2024, the Company recognized aggregate non-cash impairment charges of $76.1 million, including (i) $44.6 million primarily related to ParmCrisps ® , Thinsters ® , Joya ® , Happy, and certain North America personal care intangible assets (Alba Botanica ® , Avalon Organics ® , and JASON ® ) and (ii) a $20.7 million charge related to our Bell, CA production facility in the North America reportable segment.
During the fiscal year ended June 30, 2024, the Company recognized aggregate non-cash impairment charges of $76.1 million, including (i) $44.6 million primarily related to ParmCrisps ® , Thinsters ® , Joya ® , Happy, and certain North America personal care intangible assets (Alba Botanica ® , Avalon Organics ® , and JASON ® ) and (ii) a $20.7 million charge related to our Bell, CA production facility in the North America reportable segment.
Discussions of fiscal 2022 items and year-to-year comparisons between fiscal 2023 and fiscal 2022 that are not included in this Form 10-K can be found in “Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations” of the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2023, which was filed with the SEC on August 24, 2023 and is available on the SEC’s website at www.sec.gov.
Discussions of fiscal 2023 items and year-to-year comparisons between fiscal 2024 and fiscal 2023 that are not included in this Form 10-K can be found in “Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024, which was filed with the SEC on August 27, 2024 and is available on the SEC’s website at www.sec.gov.
Refer to Note 20, Segment Information , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for additional details. 31 Table of Contents Liquidity and Capital Resources We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below).
Refer to Note 21, Segment Information , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for additional details. 33 Table of Contents Liquidity and Capital Resources We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below).
Historically, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters. 39 Table of Contents
Historically, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters. 43 Table of Contents
See Note 7, Leases , and Note 10, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. 35 Table of Contents Critical Accounting Estimates The discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States.
See Note 8, Leases , and Note 11, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. 38 Table of Contents Critical Accounting Estimates The discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States.
For awards that contain a market condition, expense is recognized over the defined or derived service period using a Monte Carlo simulation model. 38 Table of Contents Valuation Allowances for Deferred Tax Assets Deferred tax assets arise when we recognize expenses in our financial statements that will be allowed as income tax deductions in future periods.
For awards that contain a market condition, expense is recognized over the defined or derived service period using a Monte Carlo simulation model. Valuation Allowances for Deferred Tax Assets Deferred tax assets arise when we recognize expenses in our financial statements that will be allowed as income tax deductions in future periods.
Free Cash Flow In our internal evaluations, we use the non-GAAP financial measure “Free Cash Flow.” The difference between Free Cash Flow and cash flows provided by or used in operating activities, which is the most comparable U.S. GAAP financial measure, is that Free Cash Flow reflects the impact of purchases of property, plant and equipment (capital expenditure).
Free Cash Flow In our internal evaluations, we use the non-GAAP financial measure “Free Cash Flow.” The difference between Free Cash Flow and cash flows provided by or used in operating activities, which is the most comparable U.S. GAAP financial measure, is that Free Cash Flow reflects the impact of purchases of property, plant and equipment (“capital expenditure”).
Estimates used in the guideline public company method include the identification of similar businesses with comparable business factors. 36 Table of Contents The key assumptions used in our quantitative impairment tests are inherently uncertain.
Estimates used in the guideline public company method include the identification of similar businesses with comparable business factors. The key assumptions used in our quantitative impairment tests are inherently uncertain.
Goodwill Goodwill is not amortized but rather is tested at least annually for impairment, or more often if events or changes in circumstances indicate that more likely than not the carrying amount of the asset may not be recoverable. Goodwill is tested for impairment at the reporting unit level.
Goodwill Goodwill is not amortized but rather is tested at least annually for impairment on April 1 of each year, or more often if events or changes in circumstances indicate that more likely than not the carrying amount of the asset may not be recoverable. Goodwill is tested for impairment at the reporting unit level.
The Credit Agreement provides for senior secured financing of $1,100 million in the aggregate, consisting of (1) $300 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440 million U.S. revolving credit facility and $360 million global revolving credit facility) (the “Revolver”).
The Credit Agreement originally provided for senior secured financing of $1,100.0 million in the aggregate, consisting of (1) $300.0 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800.0 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and was originally comprised of a $440.0 million U.S. revolving credit facility and $360.0 million global revolving credit facility) (the “Revolver”).
We performed a market capitalization reconciliation with the expectation that the market capitalization should reconcile within a reasonable range to the sum of the fair values of the individual reporting units. Such reconciliation often includes both qualitative and quantitative assessments as is the case with the Company’s reporting units as of March 31, 2024.
We performed a market capitalization reconciliation with the expectation that the market capitalization should reconcile within a reasonable range to the sum of the fair values of the individual reporting units. Such reconciliation often includes both qualitative and quantitative assessments as is the case with the Company’s reporting units as of June 30, 2025.
See Note 6, Property, Plant and Equipment, Net , Note 8, Goodwill and Other Intangible Assets and Note 15, Fair Value Measurements , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
See Note 7, Property, Plant and Equipment, Net , Note 9, Goodwill and Other Intangible Assets, and Note 16, Fair Value Measurements , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
Additionally, our total debt decreased by $84.7 million at June 30, 2024 to $744.1 million as compared to $828.7 million at June 30, 2023 as a result of net repayments carried out during the year. Our cash balances are held in the U.S., U.K., Canada, Western Europe, the Middle East and India.
Additionally, our total debt decreased by $39.3 million at June 30, 2025 to $704.8 million as compared to $744.1 million at June 30, 2024 as a result of net repayments carried out during the year. Our cash balances are held in the U.S., U.K., Canada, Western Europe, the Middle East and India.
Loss Before Income Taxes and Equity in Net Loss of Equity-Method Investees Loss before income taxes and equity in the net loss of our equity-method investees for fiscal 2024 was $80.3 million compared to $129.6 million in fiscal 2023. The decrease was due to the items discussed above.
Loss Before Income Taxes and Equity in Net Loss of Equity-Method Investees Loss before income taxes and equity in the net loss of our equity-method investees for fiscal 2025 was $513.7 million compared to $80.3 million in fiscal 2024. The decrease was due to the items discussed above.
A reconciliation from cash flows provided by operating activities to Free Cash Flow is as follows: Fiscal Year Ended June 30, (Amounts in thousands) 2024 2023 Net cash provided by operating activities $ 116,355 $ 66,819 Purchases of property, plant and equipment (33,461 ) (27,879 ) Free Cash Flow $ 82,894 $ 38,940 Contractual Obligations We are party to contractual obligations involving commitments to make payments to third parties, which impact our short-term and long-term liquidity and capital resource needs.
A reconciliation from cash flows provided by operating activities to Free Cash Flow is as follows: Fiscal Year Ended June 30, (Amounts in thousands) 2025 2024 Net cash provided by operating activities $ 22,115 $ 116,355 Purchases of property, plant and equipment (25,284 ) (33,461 ) Free Cash Flow $ (3,169 ) $ 82,894 Contractual Obligations We are party to contractual obligations involving commitments to make payments to third parties, which impact our short-term and long-term liquidity and capital resource needs.
For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial's products across snacks, baby & kids, beverages, meal preparation, and personal care, are marketed and sold in over 70 countries around the world.
For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby/kids, beverages and meal preparation are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.
The effective income tax rate for the year ended June 30, 2024 was primarily impacted by the recognition of a valuation allowance as a result of the reduction in deferred tax liabilities due to the above-noted impairment charges on intangible assets, offset by increased foreign earnings.
The effective income tax rate for the year ended June 30, 2025 was primarily impacted by the recognition of a valuation allowance as a result of the reduction in deferred tax liabilities due to the above-noted impairment charges on intangible assets and recognition of uncertain tax positions.
Global Economic Environment The duration and intensity of inflation fluctuations, the possibility of an impending recession, alterations in consumer shopping and consumption patterns, and shifts in geopolitical events, such as the ongoing Russia-Ukraine conflict and the continuing conflict in the Middle East, may lead to increased supply chain expenses, and other business impacts.
Global Economic Environment The duration and intensity of inflation fluctuations, alterations in consumer shopping and consumption patterns, and shifts in geopolitical events, such as the ongoing Russia-Ukraine conflict, have led and may continue to lead to increased supply chain expenses and other business impacts.
For the U.K., Western Europe, Canada, and Ella's Kitchen U.K., reporting units, the Company performed a qualitative evaluation to assess factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount.
For the qualitatively tested reporting units (U.K., Western Europe and Ella’s Kitchen U.K.), the Company assessed qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill.
Therefore, when performing an overall comparison of the sum of the fair values of the individual reporting units to the market capitalization, we included the current year fair value for reporting units for which a quantitative test was performed, and we estimated the fair 37 Table of Contents values for the reporting units for which qualitative tests were performed using a reasonable methodology.
Therefore, when performing an overall comparison of the sum of the fair values of the individual reporting units to the market capitalization, we included the current year fair value for reporting units for which a quantitative test was performed.
Equity in Net Loss of Equity-Method Investees Our equity in the net loss from our equity method investments for fiscal 2024 was $2.6 million compared to $1.1 million for fiscal 2023. The change was attributable to higher investee losses. See Note 14, Investments , in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
See Note 12, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information. Equity in Net Loss of Equity-Method Investees Our equity in the net loss from our equity method investments for fiscal 2025 was $1.8 million compared to $2.6 million for fiscal 2024.
Our cash and cash equivalents balance increased $0.9 million at June 30, 2024 to $54.3 million as compared to $53.4 million at June 30, 2023. Our working capital was $275.6 million at June 30, 2024, a decrease of $83.4 million from $358.9 million at the end of fiscal 2023.
Cash and Cash Equivalents Our cash and cash equivalents balance was relatively consistent at June 30, 2025 at $54.4 million as compared to $54.3 million at June 30, 2024. Our working capital was $252.9 million at June 30, 2025, a decrease of $22.7 million from $275.6 million at the end of fiscal 2024.
Adjusted EBITDA Our consolidated Adjusted EBITDA was $154.5 million and $166.6 million for fiscal 2024 and 2023, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S.
Adjusted EBITDA Our consolidated Adjusted EBITDA was $113.8 million and $154.5 million for fiscal 2025 and 2024, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation of our net income to Adjusted EBITDA.
The Company's leading brands include Garden Veggie Snacks, Terra ® chips, Garden of Eatin' ® snacks, Hartley’s ® Jelly, Earth's Best ® and Ella's Kitchen ® baby and kids foods, Celestial Seasonings ® teas, Joya ® and Natumi ® plant-based beverages, Greek Gods ® yogurt, Cully & Sully ® , Yorkshire Provender ® , New Covent Garden ® and Imagine ® soups, Yves ® and Linda McCartney's ® (under license) meat-free, and Avalon Organics ® personal care, among others.
The Company ’ s leading brands include Garden Veggie Snacks , Terra ® chips, Garden of Eatin’ ® snacks, Hartley’s ® jelly, Earth’s Best ® Organic and Ella’s Kitchen ® baby and kid’s foods, Celestial Seasonings ® teas, Joya ® and Natumi ® plant-based beverages, The Greek Gods ® yogurt, Cully & Sully ® , Yorkshire Provender ® , New Covent Garden ® and Imagine ® soups, among others.
A reconciliation of net loss to Adjusted EBITDA is as follows: 34 Table of Contents Fiscal Year Ended June 30, (Amounts in thousands) 2024 2023 Net loss $ (75,042 ) $ (116,537 ) Depreciation and amortization 44,665 50,777 Equity in net loss of equity-method investees 2,581 1,134 Interest expense, net 54,232 43,936 Benefit for income taxes (7,820 ) (14,178 ) Stock-based compensation, net 12,704 14,423 Unrealized currency losses 17 929 Litigation and related costs (a) 7,262 (1,369 ) Restructuring activities Productivity and transformation costs 27,741 7,284 Plant closure related costs, net 5,251 94 Warehouse/manufacturing consolidation and other costs, net 995 1,026 CEO succession — 5,113 Acquisitions, divestitures and other Loss (gain) on sale of assets 4,384 (3,529 ) Transaction and integration costs, net (34 ) 2,018 Impairment charges Intangibles and long-lived asset impairment 76,143 175,501 Other 1,443 — Adjusted EBITDA $ 154,522 $ 166,622 (a) Expenses and items relating to securities class action, baby food litigation, and SEC investigation.
GAAP results. 37 Table of Contents A reconciliation of net loss to Adjusted EBITDA is as follows: Fiscal Year Ended June 30, (Amounts in thousands) 2025 2024 Net loss $ (530,841 ) $ (75,042 ) Depreciation and amortization 44,259 44,665 Equity in net loss of equity-method investees 1,813 2,581 Interest expense, net 47,773 54,232 Provision (benefit) for income taxes 15,297 (7,820 ) Stock-based compensation, net 8,149 12,704 Unrealized and certain realized currency losses 3,823 17 Certain litigation expenses, net (a) 3,473 7,262 Restructuring activities Productivity and transformation costs 21,530 27,741 Plant closure related costs, net 1,215 5,251 Warehouse/manufacturing consolidation and other costs, net 384 995 CEO succession 4,774 — Acquisitions, divestitures and other (Gain) loss on sale of assets (3,194 ) 4,384 Transaction and integration costs, net (488 ) (34 ) Impairment charges Goodwill impairment 428,882 — Intangibles and long-lived asset impairment 66,940 76,143 Other — 1,443 Adjusted EBITDA $ 113,789 $ 154,522 (a) Expenses and items relating to securities class action, baby food litigation, and SEC investigation.
GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.
GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S.
Hot tea, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our personal care products are stronger in the warmer months.
Hot tea and soup sales are stronger in colder months, while sales of snack foods are stronger in the warmer months.
The program is intended to optimize our portfolio, improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth.
The savings initiatives impact our reportable segments and Corporate and Other. The program is intended to optimize our portfolio, improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. Implementation of the Restructuring Program is expected to be completed by the end of the 2027 fiscal year.
Adjusted EBITDA in fiscal 2024 was $98.7 million, a decrease of $24.7 million from $123.4 million in fiscal 2023. The decrease was primarily driven by lower volume and inflation, partially offset by pricing. Adjusted EBITDA margin was 9.4%, a 148-basis point decrease from the prior year.
Adjusted EBITDA in fiscal 2025 was $86.0 million, a decrease of $9.0 million from $95.0 million in fiscal 2024. The decrease was primarily driven by inflation and volume and mix softness, partially offset by productivity and pricing. Adjusted EBITDA margin was 12.8%, a 120-basis point decrease from the prior year.
The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio.
The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement.
Other expense, net primarily reflected the recognition of a loss on sale of the Thinsters ® cookie business and Queen Helene ® brand and net foreign currency gains during fiscal 2024.
These gains were partially offset by a $3.9 million pretax loss recognized on the sale of ParmCrisps ® .and net foreign currency losses. Other expense, net in fiscal 2024 primarily reflected losses on the dispositions of Thinsters ® cookie business and Queen Helene ® brand, partially offset by net foreign currency gains.
We use this risk-based approach to determine which brands we would quantitatively test for impairment, whether as part of fiscal year annual impairment testing or an interim period test.
We use this risk-based approach to determine which brands we would quantitatively test for impairment, whether as part of fiscal year annual impairment testing or an interim period test. During the fourth quarter of fiscal 2025, the Company quantitatively tested tradenames associated with its snacks and meal preparation brands, Sensible Portions ® , Imagine ® and Spectrum ® .
The balance of cumulative pretax restructuring charges is expected to be $90 million - $100 million comprised of contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses.
Cumulative pretax charges associated with the Restructuring Program are expected to be $100 million - $110 million comprised of contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses, which represents an increase of $10 million from the previously reported range.
Amended and Restated Credit Agreement On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement (as amended, the “Credit Agreement”).
Amended and Restated Credit Agreement On December 22, 2021, the Company entered into a Fourth Amended and Restated Credit Agreement (as subsequently amended, the “Credit Agreement”).
GAAP Measures Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.
GAAP Measures We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors. For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S.
See Note 4, Dispositions , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. Cash used in financing activities was $89.7 million for the fiscal year ended June 30, 2024, an increase of $26.7 million compared to $63.1 million in the prior year.
See Note 5, Dispositions and Note 15, Investments, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. 35 Table of Contents Cash used in financing activities was $43.9 million for the fiscal year ended June 30, 2025, a decrease of $45.8 million compared to $89.7 million in the prior year, primarily reflecting a reduction in the repayment of borrowings.
During the Second Amendment Period, loans under the Credit Agreement bears interest at (a) Term SOFR plus 2.5% per annum or (b) the Base Rate plus 1.5% per annum.
Commencing on the date of the Third Amendment, loans under the Credit Agreement bore interest at (a) Term SOFR plus 3.00% per annum or (b) the Base Rate plus 2.00% per annum.
Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2024 was 6.83%.
As of June 30, 2025, the notional amount of the interest rate swaps was $400.0 million with fixed rate payments of 6.12%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 6.41%.
The effect of fluctuations in foreign currency exchange rates increased net sales by $26.4 million. Further details of changes in net sales by segment are provided below in the Segment Results section. Gross Profit Gross profit in fiscal 2024 was $380.8 million, a decrease of $15.6 million, or 3.9%, from $396.4 million in fiscal 2023.
Further details of changes in net sales by segment are provided below in the Segment Results section. Gross Profit Gross profit in fiscal 2025 was $334.1 million, a decrease of $46.8 million, or 12.3%, from $380.8 million in fiscal 2024. Gross profit margin was 21.4% of net sales, compared to 21.9% in the prior year.
Results of Operations Comparison of Fiscal Year Ended June 30, 2024 to Fiscal Year Ended June 30, 2023 Consolidated Results The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the fiscal years ended June 30, 2024 and 2023 (dollars in thousands, other than per share amounts and percentages, which may not add due to rounding): Fiscal Year Ended June 30, Change in 2024 2023 Dollars Percentage Net sales $ 1,736,286 100.0 % $ 1,796,643 100.0 % $ (60,357 ) (3.4 )% Cost of sales 1,355,454 78.1 % 1,400,229 77.9 % (44,775 ) (3.2 )% Gross profit 380,832 21.9 % 396,414 22.1 % (15,582 ) (3.9 )% Selling, general and administrative expenses 290,116 16.7 % 289,233 16.1 % 883 0.3 % Intangibles and long-lived asset impairment 76,143 4.4 % 175,501 9.8 % (99,358 ) (56.6 )% Productivity and transformation costs 27,741 1.6 % 7,284 0.4 % 20,457 280.8 % Amortization of acquired intangible assets 5,780 0.3 % 10,016 0.6 % (4,236 ) (42.3 )% Operating loss (18,948 ) (1.1 )% (85,620 ) (4.8 )% 66,672 (77.9 )% Interest and other financing expense, net 57,213 3.3 % 45,783 2.5 % 11,430 25.0 % Other expense (income), net 4,120 0.2 % (1,822 ) (0.1 )% 5,942 * Loss before income taxes and equity in net loss of equity-method investees (80,281 ) (4.6 )% (129,581 ) (7.2 )% 49,300 (38.0 )% Benefit for income taxes (7,820 ) (0.5 )% (14,178 ) (0.8 )% 6,358 (44.8 )% Equity in net loss of equity-method investees 2,581 0.1 % 1,134 0.1 % 1,447 127.6 % Net loss $ (75,042 ) (4.3 )% $ (116,537 ) (6.5 )% $ 41,495 (35.6 )% Adjusted EBITDA $ 154,522 8.9 % $ 166,622 9.3 % $ (12,100 ) (7.3 )% Basic and diluted net loss per common share $ (0.84 ) $ (1.30 ) $ 0.46 (35.4 )% * Percentage is not meaningful due to one or more amounts being negative. 28 Table of Contents Net Sales Net sales in fiscal 2024 were $1.74 billion, a decrease of $60.4 million, or 3.4%, from net sales of $1.80 billion in fiscal 2023.
Results of Operations Comparison of Fiscal Year Ended June 30, 2025 to Fiscal Year Ended June 30, 2024 Consolidated Results The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the fiscal years ended June 30, 2025 and 2024 (dollars in thousands, other than per share amounts and percentages, which may not add due to rounding): Fiscal Year Ended June 30, Change in 2025 2024 Dollars Percentage Net sales $ 1,559,780 100.0 % $ 1,736,286 100.0 % $ (176,506 ) (10.2 )% Cost of sales 1,225,722 78.6 % 1,355,454 78.1 % (129,732 ) (9.6 )% Gross profit 334,058 21.4 % 380,832 21.9 % (46,774 ) (12.3 )% Selling, general and administrative expenses 271,833 17.4 % 290,116 16.7 % (18,283 ) (6.3 )% Goodwill impairment 428,882 27.5 % — — 428,882 ** Intangibles and long-lived asset impairment 66,940 4.3 % 76,143 4.4 % (9,203 ) (12.1 )% Productivity and transformation costs 21,530 1.4 % 27,741 1.6 % (6,211 ) (22.4 )% Amortization of acquired intangible assets 6,476 0.4 % 5,780 0.3 % 696 12.0 % Operating loss (461,603 ) (29.6 )% (18,948 ) (1.1 )% (442,655 ) ** Interest and other financing expense, net 51,253 3.3 % 57,213 3.3 % (5,960 ) (10.4 )% Other expense, net 875 0.1 % 4,120 0.2 % (3,245 ) (78.8 )% Loss before income taxes and equity in net loss of equity-method investees (513,731 ) (32.9 )% (80,281 ) (4.6 )% (433,450 ) ** Provision (benefit) for income taxes 15,297 1.0 % (7,820 ) (0.5 )% 23,117 * Equity in net loss of equity-method investees 1,813 0.1 % 2,581 0.1 % (768 ) (29.8 )% Net loss $ (530,841 ) (34.0 )% $ (75,042 ) (4.3 )% $ (455,799 ) ** Adjusted EBITDA $ 113,789 7.3 % $ 154,522 8.9 % $ (40,733 ) (26.4 )% Basic and diluted net loss per common share $ (5.89 ) $ (0.84 ) $ (5.05 ) ** * Percentage is not meaningful due to one or more amounts being negative. ** Percentage is not meaningful due to significantly lower number or nil value in the comparative period. 29 Table of Contents Net Sales Net sales in fiscal 2025 were $1.56 billion, a decrease of $176.5 million, or 10.2%, from net sales of $1.74 billion in fiscal 2024.
This increase versus the prior year resulted primarily from higher cash generation of $101.7 million from our working capital accounts, which was driven by our accounts payable optimization initiatives and focused inventory management, partially offset by a reduction in accounts receivable recovery.
This decrease in cash provided by operating activities versus the prior year resulted primarily from a reduction in cash earnings and higher cash utilization of $41.6 million for our working capital accounts, which was mainly due to higher inventory and a reduced benefit from accounts payable and accrued expenses, partially offset by an increase in accounts receivable recovery.
The increase was also partially offset by a reduction of $52.1 million in net loss adjusted for non-cash charges in the current year. Cash used in investing activities was $23.9 million for the fiscal year ended June 30, 2024, an increase of $4.3 million from $19.6 million in the prior year.
Cash provided by investing activities was $3.6 million for the fiscal year ended June 30, 2025, an increase of $27.5 million from cash used in investing activities of $23.9 million in the prior year.
Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023 and 5.00:1.00 until December 31, 2024 (the period of time during which such maximum consolidated secured leverage ratios are in effect, the “Second Amendment Period”).
Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023, 5.00:1.00 until December 31, 2024, and 4.25:1.00 thereafter. See below for a description of the Third Amendment and Fourth Amendment (each as defined below).
The GPCM approach estimates the value of a reporting unit through analysis of recent sales of comparable assets or business entities by comparing it to comparable publicly-disclosed transactions in similar businesses.
The assumptions we use in our tests include projections of growth rates and profitability, our estimated working capital needs, as well as our weighted average cost of capital (“WACC”). 39 Table of Contents The GPCM approach estimates the value of a reporting unit through analysis of recent sales of comparable assets or business entities by comparing it to comparable publicly-disclosed transactions in similar businesses.
Benefit for Income Taxes The benefit for income taxes includes federal, foreign, state and local income taxes. Our income tax benefit was $7.8 million for fiscal 2024 compared to $14.2 million for fiscal 2023. The effective income tax rate was 9.7% and 10.9% of pre-tax income for the fiscal year ended June 30, 2024 and 2023, respectively.
Provision (benefit) for Income Taxes The provision (benefit) for income taxes includes federal, foreign, state and local income taxes. Our income tax expense was $15.3 million for fiscal 2025 compared to a benefit of $7.8 million for fiscal 2024.
Considerable management judgment is necessary to evaluate the impact of operating and external economic factors in estimating our future cash flows. The assumptions we use in our tests include projections of growth rates and profitability, our estimated working capital needs, as well as our weighted average cost of capital (“WACC”).
Considerable management judgment is necessary to evaluate the impact of operating and external economic factors in estimating our future cash flows.
Cash provided by (used in) operating, investing and financing activities is summarized below. 32 Table of Contents Fiscal Year Ended June 30, (Amounts in thousands) 2024 2023 Change in Dollars Cash flows provided by (used in): Operating activities $ 116,355 $ 66,819 $ 49,536 Investing activities (23,922 ) (19,640 ) (4,282 ) Financing activities (89,729 ) (63,060 ) (26,669 ) Effect of exchange rate changes on cash (1,761 ) 3,733 (5,494 ) Net increase (decrease) in cash and cash equivalents $ 943 $ (12,148 ) $ 13,091 Cash provided by operating activities was $116.4 million for the fiscal year ended June 30, 2024, an increase of $49.5 million from $66.8 million in the prior year.
Fiscal Year Ended June 30, (Amounts in thousands) 2025 2024 Change in Dollars Cash flows provided by (used in): Operating activities $ 22,115 $ 116,355 $ (94,240 ) Investing activities 3,619 (23,922 ) 27,541 Financing activities (43,886 ) (89,729 ) 45,843 Effect of exchange rate changes on cash 18,200 (1,761 ) 19,961 Net increase in cash and cash equivalents $ 48 $ 943 $ (895 ) Cash provided by operating activities was $22.1 million for the fiscal year ended June 30, 2025, a decrease of $94.2 million from cash provided by operating activities of $116.4 million in the prior year.
GAAP Measures following the discussion of our results of operations for definitions and a reconciliation of our net income to Adjusted EBITDA. 30 Table of Contents Segment Results The following table provides a summary of net sales and Adjusted EBITDA by reportable segment for the fiscal years ended June 30, 2024 and 2023: (Dollars in thousands) North America International Corporate and Other Consolidated Net Sales Fiscal 2024 $ 1,055,527 $ 680,759 $ — $ 1,736,286 Fiscal 2023 $ 1,139,162 $ 657,481 $ — $ 1,796,643 $ change $ (83,635 ) $ 23,278 n/a $ (60,357 ) % change (7.3 )% 3.5 % n/a (3.4 )% Adjusted EBITDA Fiscal 2024 $ 98,728 $ 94,974 $ (39,180 ) $ 154,522 Fiscal 2023 $ 123,443 $ 82,945 $ (39,766 ) $ 166,622 $ change $ (24,715 ) $ 12,029 $ 586 $ (12,100 ) % change (20.0 )% 14.5 % 1.5 % (7.3 )% Adjusted EBITDA margin Fiscal 2024 9.4 % 14.0 % n/a 8.9 % Fiscal 2023 10.8 % 12.6 % n/a 9.3 % See the Reconciliation of Non-U.S.
Segment Results The following table provides a summary of net sales and Adjusted EBITDA by reportable segment for the fiscal years ended June 30, 2025 and 2024: (Dollars in thousands) North America International Corporate and Other Consolidated Net Sales Fiscal 2025 $ 888,626 $ 671,154 $ — $ 1,559,780 Fiscal 2024 $ 1,055,527 $ 680,759 $ — $ 1,736,286 $ change $ (166,901 ) $ (9,605 ) n/a $ (176,506 ) % change (15.8 )% (1.4 )% n/a (10.2 )% Adjusted EBITDA Fiscal 2025 $ 65,470 $ 86,000 $ (37,681 ) $ 113,789 Fiscal 2024 $ 98,728 $ 94,974 $ (39,180 ) $ 154,522 $ change $ (33,258 ) $ (8,974 ) $ 1,499 $ (40,733 ) % change (33.7 )% (9.4 )% 3.8 % (26.4 )% Adjusted EBITDA margin Fiscal 2025 7.4 % 12.8 % n/a 7.3 % Fiscal 2024 9.4 % 14.0 % n/a 8.9 % See the Reconciliation of Non-U.S.
See Note 10, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. Other Expense (Income), Net Other expense, net totaled $4.1 million in fiscal 2024 compared to other income, net of $1.8 million in the prior year.
The decrease resulted primarily from a lower outstanding debt balance and the impact of a reduction in borrowing rates compared to the prior year. See Note 11, Debt and Borrowings , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
As of June 30, 2024, there were $475.0 million of loans under the Revolver, $270.6 million of Term Loans, and $3.2 million of letters of credit outstanding under the Credit Agreement. As of June 30, 2024 and June 30, 2023, $321.8 million and $254.5 million, respectively, was available under the Credit Agreement, subject to compliance with the financial covenants.
As of June 30, 2025 and June 30, 2024, $246.7 million and $321.8 million, respectively, was available under the Credit Agreement, subject to compliance with the financial covenants. As of June 30, 2025, the Company was in compliance with all associated covenants.
Net Loss Net loss for fiscal 2024 was $75.0 million, or $0.84 per diluted share, compared to $116.5 million, or $1.30 per diluted share, in fiscal 2023. The change was attributable to the factors noted above.
See Note 15, Investments , in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K. 31 Table of Contents Net Loss Net loss for fiscal 2025 was $530.8 million, or $5.91 per diluted share, compared to $75.0 million, or $0.84 per diluted share, in fiscal 2024. The change was attributable to the factors noted above.
Our effective tax rate may change from period-to-period based on recurring and nonrecurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements. See Note 11, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information.
The effective income tax rate for the year ended June 30, 2024 was primarily impacted by the recognition of a valuation allowance against deferred tax assets. Our effective tax rate may change from period-to-period based on recurring and nonrecurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
As of June 30, 2024, the Company’s consolidated secured leverage ratio, consolidated leverage ratio and consolidated interest coverage ratio were 3.74:1.00, 3.74:1.00 and 3.43:1.00, respectively, and the Company was in compliance with all associated covenants.
As of June 30, 2025, the Company’s consolidated secured leverage ratio, consolidated leverage ratio and consolidated interest coverage ratio were 4.69:1.00, 4.69:1.00 and 2.93:1.00, respectively, and the Company was in compliance with all associated covenants. The aforementioned financial covenants are being reported as calculated under the Credit Agreement and not pursuant to accounting principles generally accepted in the U.S. (“GAAP”).
The Company concluded that for the reporting units where a qualitative evaluation was performed that the reporting units’ estimated fair values exceeded their carrying amounts.
The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts, while noting a recent decline in performance within the U.K. reporting units.
See Note 8, Goodwill and Other Intangible Assets , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. 29 Table of Contents Operating Loss Operating loss in fiscal 2024 was $18.9 million compared to $85.6 million in fiscal 2023 due to the items described above.
See Note 4, Assets and Liabilities Held for Sale , Note 9, Goodwill and Other Intangible Assets and Note 16, Fair Value Measurements , in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
Productivity and transformation costs of $27.7 million in fiscal 2024 are primarily comprised of consultancy and employee-related costs in the amount of $20.7 million and $7.0 million, respectively. Both costs are associated with the Hain Reimagined Program.
Productivity and transformation costs of $21.5 million in fiscal 2025 were primarily comprised of consultancy and employee-related costs in the amount of $13.2 million and $8.3 million, respectively.
Following the Second Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00. Pursuant to the Second Amendment, the Company’s minimum interest coverage ratio was amended to be 2.50:1.00.
Following the Fourth Amendment, the Company’s maximum consolidated secured leverage ratio under the Credit Agreement was 5.00:1.00 until June 30, 2025 and is 5.50:1.00 for the quarter ending September 30, 2025 and thereafter. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00 and, through June 30, 2025, its minimum interest coverage ratio was 2.50:1.00.
The increase in Free Cash Flow primarily resulted from an increase in cash flow provided by operations of $49.5 million driven by the reasons explained above, partially offset by higher capital expenditures. See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S.
Free Cash Flow Our Free Cash Flow was negative $3.2 million for fiscal 2025, a decrease of $86.1 million from fiscal 2024. This year-over-year decline was primarily driven by a $94.2 million reduction in cash flows from operating activities, as explained above, partially offset by lower capital expenditures. See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S.
The Company’s management believes that excluding the impact of divestitures and discontinued brands when presenting period-over-period results of net sales aids in comparability. 33 Table of Contents To present net sales adjusted for the impact of divestitures and discontinued brands, the net sales of a divested business or discontinued brand are excluded from all periods.
To adjust organic net sales for the impact of divestitures, held for sale businesses, discontinued brands and exited product categories, the net sales of a divested business, held for sale business, discontinued brand or exited product category are excluded from all periods.
During the fourth quarter of 2024, the North America personal care tradenames were reclassified from indefinite to definite-lived and ascribed a useful life of 10 years. See Note 8, Goodwill and Other Intangible Assets in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
The increase was due to the fact that during the fourth quarter of fiscal 2024, personal care tradenames and MaraNatha ® and Happy TM and Joya ® trademarks were reclassified from indefinite to definite-lived and ascribed a useful life of 10 years.
We continually assess the nature and extent of these potential and evolving impacts on our business, consolidated operational results, liquidity, and capital resources.
Moreover, our industry has experienced and is anticipating the possibility of further increased supply chain challenges, input cost increases and consumer and economic uncertainty as a result of U.S. government tariffs and the imposition of any counter-tariffs. We continually assess the nature and extent of these potential and evolving impacts on our business, consolidated operational results, liquidity, and capital resources.
Hain Reimagined Program During the first quarter of fiscal year 2024, we initiated a multi-year growth, transformation and restructuring program (the “Hain Reimagined Program”) intended to drive shareholder returns. The savings initiatives impact our reportable segments and Corporate and Other.
Also, in the third quarter of fiscal year 2025, we announced that we were exploring strategic alternatives regarding our personal care business to focus on our portfolio of better-for-you food and beverages. Restructuring Program During the first quarter of fiscal year 2024, we initiated a multi-year growth, transformation and restructuring program (the “Restructuring Program”) intended to drive shareholder returns.
Interest and Other Financing Expense, Net Interest and other financing expense, net totaled $57.2 million in fiscal 2024, an increase of $11.4 million, or 25.0%, from $45.8 million in the prior year. The increase resulted primarily from higher borrowing rates, partially offset by a lower outstanding debt balance compared to the prior year.
Operating Loss Operating loss in fiscal 2025 was $461.6 million compared to $18.9 million in fiscal 2024 due to the items described above. Interest and Other Financing Expense, Net Interest and other financing expense, net totaled $51.3 million in fiscal 2025, a decrease of $6.0 million, or 10.4%, from $57.2 million in the prior year.
Gross profit margin was 21.9% of net sales, compared to 22.1% in the prior year. The decrease in gross profit was driven primarily by the North America reportable segment, mainly due to lower sales volume as well as by inflation and an increase in plant closure and warehouse consolidation related costs, partially offset by pricing and productivity.
The decrease in gross profit was driven primarily by the North America reportable segment, mainly due to volume and mix softness along with higher trade spend and inflation, partially offset by productivity improvements. Gross profit also decreased in the International reportable segment mainly due to inflation and volume and mix softness, partially offset by productivity and pricing.
Net sales, adjusted for the impact of divestitures and discontinued brands, decreased approximately $42.8 million, or 2.4%, from the prior year. The decrease in both net sales and adjusted net sales was due to a decline in the North America reportable segment, partially offset by growth in the International reportable segment.
North America Our net sales in the North America reportable segment for fiscal 2025 were $888.6 million, a decrease of $166.9 million, or 15.8%, including an unfavorable impact of $85.2 million, or 6.4%, related to divestitures, held for sale businesses, discontinued brands and exited product categories, as compared to the prior year.
As a result of indicators of impairment which included a significant decline in the Company’s market capitalization and impairment charges recorded during the three months ended March 31, 2024 within the U.S. reporting unit (see Note 8, Goodwill and Other Intangible Assets and Note 6, Property, Plant and Equipment, Net in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K), the Company completed an interim impairment test of all reporting units.
Consequently, the Company recorded aggregate non-cash goodwill impairment charges of $357.7 million within the North America segment related to such reporting units and $71.2 million within the International segment related to its U.K. reporting unit. See Note 9, Goodwill and Other Intangible Assets , in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
Other income, net was primarily comprised of a gain on sale of the Westbrae Natural ® brand (“Westbrae”), partially offset by the recognition of net foreign currency losses in the prior year. See Note 4, Dispositions , in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
See Note 5, Dispositions and Note 15, Investments , in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
During fiscal 2022, the Company used interest rate swaps to hedge a portion of the interest rate risk related its outstanding variable rate debt. As of June 30, 2024, the notional amount of the interest rate swaps was $400 million with fixed rate payments of 5.60%.
Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 7.34%. The Company uses interest rate swaps to hedge a portion of the interest rate risk related to its outstanding variable rate debt.
Productivity and Transformation Costs Productivity and transformation costs were $27.7 million in fiscal 2024, an increase of $20.5 million or 280.8% from $7.3 million in fiscal 2023.
Productivity and Transformation Costs Productivity and transformation costs were $21.5 million in fiscal 2025, a decrease of $6.2 million or 22.4% from $27.7 million in fiscal 2024. The decrease primarily reflected a reduction in restructuring costs incurred in connection with the Restructuring Program.
Following the Second Amendment Period, loans bear interest at rates based on (a) Term SOFR plus a rate ranging from 1.125% to 2.0% per annum or (b) the Base Rate plus a rate ranging from 0.125% to 1.0% per annum, the relevant rate in each case being the Applicable Rate.
Commencing on the date of the Fourth Amendment, loans under the Credit Agreement bear interest at (a) Term SOFR plus 4.00% per annum or (b) the Base Rate plus 3.00% per annum.
Valuation of Long-lived Assets Fixed assets and amortizable intangible assets are reviewed for impairment as events or changes in circumstances occur indicating that the carrying value of the asset may not be recoverable. Undiscounted cash flow analyses are used to determine if impairment exists. If impairment is determined to exist, the loss is calculated based on estimated fair value.
Valuation of Long-lived Assets The Company periodically evaluates the carrying value of long-lived assets held and used in the business and with definite lives, when events and circumstances occur indicating that the carrying amount of the asset or its asset group may not be recoverable.
The decrease in net sales was primarily due to lower sales in the baby & kids category on account of continued industry-wide challenges in organic formula supply as well as decline in the personal care category. The decrease was partially offset by growth in the beverage category.
The decrease in organic net sales was largely attributable to softness in the snacks category, as a result of velocity challenges and distribution losses, and to a lesser extent, by lower sales in the meal preparation category. The decline in meal preparation was primarily driven by softness in oils and nut butters, partially offset by growth in yogurt.